R J van Alphen

Statistics

Publications

Citations

948

H-Index

Active since

1998

Affiliations

Rotterdam University of Applied Sciences(Current)

R J van Alphen is an author at Rotterdam University of Applied Sciences specializing in medicinal chemistry, cancer therapeutics, and pharmacotherapy.

Top concepts

MedicineBiochemistryPharmacologyCancer TherapyDrug DiscoveryCancer ResearchPharmacotherapyNatural SciencesMedicinal ChemistryOncology

Publications per year

1998–2017

Publications

Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

Ron H.J. Mathijssen, R J van Alphen, Jaco J. Verweij et al. · PubMed · 2001 · 752 citations

Cpt-11 Belongs, Chemoprevention Strategy, Pharmacotherapy +18

Irinotecan (CPT-11) metabolism and disposition in cancer patients.

Alex Sparreboom, M J de Jonge, Peter de Bruijn et al. · PubMed · 1998 · 115 citations

Fecal Excretion, Medicinal Chemistry, Oncology +15

Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group

Johannes J.M. Kwakman, Lieke H. J. Simkens, Johan M. van Rooijen et al. · Annals of Oncology · 2017 · 81 citations

Rows per page

1–3 of 3